Literature DB >> 19906326

One size fits all? Why we need more sophisticated analytical methods in the explanation of trajectories of cognition in older age and their potential risk factors.

Graciela Muniz Terrera1, Carol Brayne, Fiona Matthews.   

Abstract

BACKGROUND: Cognitive decline in old age varies among individuals. The identification of groups of individuals with similar patterns of cognitive change over time may improve our ability to see whether the effect of risk factors is consistent across groups.
METHODS: Whilst accounting for the missing data, growth mixture models (GMM) were fitted to data from four interview waves of a population-based longitudinal study of aging, the Cambridge City over 75 Cohort Study (CC75C). At all interviews global cognition was assessed using the Mini-mental State Examination (MMSE).
RESULTS: Three patterns were identified: a slow decline with age from a baseline of cognitive ability (41% of sample), an accelerating decline from a baseline of cognitive impairment (54% of sample) and a steep constant decline also from a baseline of cognitive impairment (5% of sample). Lower cognitive scores in those with less education were seen at baseline for the first two groups. Only in those with good performance and steady decline was the effect of education strong, with an increased rate of decline associated with poor education. Good mobility was associated with higher initial score in the group with accelerating change but not with rate of decline.
CONCLUSION: Using these analytical methods it is possible to detect different patterns of cognitive change with age. In this investigation the effect of education differs with group. To understand the relationship of potential risk factors for cognitive decline, careful attention to dropout and appropriate analytical methods, in addition to long-term detailed studies of the population points, are required.

Entities:  

Mesh:

Year:  2009        PMID: 19906326     DOI: 10.1017/S1041610209990937

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  25 in total

Review 1.  Bringing prevention in geriatrics: evidences from cardiovascular medicine supporting the new challenge.

Authors:  Angelo Scuteri; Edward G Lakatta
Journal:  Exp Gerontol       Date:  2012-03-03       Impact factor: 4.032

2.  Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: conceptual framework and example.

Authors:  Jeannie-Marie S Leoutsakos; Alexandra L Bartlett; Sarah N Forrester; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2013-08-15       Impact factor: 21.566

3.  Cognitive decline in the elderly: an analysis of population heterogeneity.

Authors:  Kathleen M Hayden; Bruce R Reed; Jennifer J Manly; Douglas Tommet; Robert H Pietrzak; Gordon J Chelune; Frances M Yang; Andrew J Revell; David A Bennett; Richard N Jones
Journal:  Age Ageing       Date:  2011-09-02       Impact factor: 10.668

4.  Cognitive ageing trajectories and mortality of Chinese oldest-old.

Authors:  Xiaoqian Hu; Shuyan Gu; Xueshan Sun; Yuxuan Gu; Xuemei Zhen; Yuanyuan Li; Minzhuo Huang; Jingming Wei; Hengjin Dong
Journal:  Arch Gerontol Geriatr       Date:  2019-01-29       Impact factor: 3.250

5.  Coordinated analysis of age, sex, and education effects on change in MMSE scores.

Authors:  Andrea M Piccinin; Graciela Muniz-Terrera; Sean Clouston; Chandra A Reynolds; Valgeir Thorvaldsson; Ian J Deary; Dorly J H Deeg; Boo Johansson; Andrew Mackinnon; Avron Spiro; John M Starr; Ingmar Skoog; Scott M Hofer
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2012-10-02       Impact factor: 4.077

6.  Cognitive Aging Trajectories and Burdens of Disability, Hospitalization and Nursing Home Admission Among Community-living Older Persons.

Authors:  Ling Han; Thomas M Gill; Bobby L Jones; Heather G Allore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-10-28       Impact factor: 6.053

7.  Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial.

Authors:  Jeannie-Marie S Leoutsakos; Bengt O Muthen; John C S Breitner; Constantine G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2011-05-10       Impact factor: 3.485

8.  Trajectory classes of depression in a randomized depression trial of heart failure patients: a reanalysis of the SADHART-CHF trial.

Authors:  Maragatha N Kuchibhatla; Gerda G Fillenbaum
Journal:  Am J Geriatr Pharmacother       Date:  2011-10-28

9.  An examination of the heterogeneity in the pattern and association between rates of change in grip strength and global cognition in late life. A multivariate growth mixture modelling approach.

Authors:  Annie Robitaille; Andrea M Piccinin; Scott M Hofer; Boo Johansson; Graciela Muniz Terrera
Journal:  Age Ageing       Date:  2018-09-01       Impact factor: 10.668

10.  Late-life memory trajectories in relation to incident dementia and regional brain atrophy.

Authors:  Laura B Zahodne; Melanie M Wall; Nicole Schupf; Richard Mayeux; Jennifer J Manly; Yaakov Stern; Adam M Brickman
Journal:  J Neurol       Date:  2015-08-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.